Recovering Misplacing Errors with QRL-201 & QRL-101 to Restore Function & Reduce Disease Burden in ALS
Time: 11:00 am
day: Conference Day Two Workshop B
Details:
- Understanding QRL-201 and QRL-101 mechanisms for restoring STMN2 expression and reducing hyperexcitability induced neurodegeneration in ALS, using FlexASO splicing technology to correct misplacing
- Unveiling preliminary trial results showcasing QRL-201 efficacy and safety data in humans
- Identifying potential subgroups that may benefit from more personalized approaches
